93 related articles for article (PubMed ID: 2985415)
1. Stem cell defects after cytoreductive therapy in man.
Schreml W; Lohrmann HP; Anger B
Exp Hematol; 1985; 13 Suppl 16():31-42. PubMed ID: 2985415
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow connexin-43 expression is critical for hematopoietic regeneration after chemotherapy.
Presley CA; Lee AW; Kastl B; Igbinosa I; Yamada Y; Fishman GI; Gutstein DE; Cancelas JA
Cell Commun Adhes; 2005; 12(5-6):307-17. PubMed ID: 16531325
[TBL] [Abstract][Full Text] [Related]
3. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
[TBL] [Abstract][Full Text] [Related]
4. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
5. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
6. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant.
Selleri C; Maciejewski JP; De Rosa G; Raiola A; Risitano AM; Picardi M; Pezzullo L; Luciano L; Ricci P; Varriale G; Della Cioppa P; Del Vecchio L; Rotoli B
Bone Marrow Transplant; 1999 May; 23(10):1029-37. PubMed ID: 10373069
[TBL] [Abstract][Full Text] [Related]
7. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S
Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents.
Neben S; Hellman S; Montgomery M; Ferrara J; Mauch P
Exp Hematol; 1993 Jan; 21(1):156-62. PubMed ID: 8435103
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
10. The synthetic tetrapeptide AcSDKP protects cells that reconstitute long-term bone marrow stromal cultures from the effects of mafosfamide (Asta Z 7654).
Genevay MC; Mormont C; Thomas F; Berthier R
Exp Hematol; 1996 Jan; 24(1):77-81. PubMed ID: 8536796
[TBL] [Abstract][Full Text] [Related]
11. Efficacious but insidious: a retrospective analysis of fludarabine-induced myelotoxicity using long-term culture-initiating cells in 100 follicular lymphoma patients.
Janikova A; Koristek Z; Vinklarkova J; Pavlik T; Sticha M; Navratil M; Kral Z; Vasova I; Mayer J
Exp Hematol; 2009 Nov; 37(11):1266-73. PubMed ID: 19654036
[TBL] [Abstract][Full Text] [Related]
12. 5-fluorouracil permits access to a primitive subpopulation of peripheral blood stem cells.
Rice A; Barbot C; Lacombe F; Dubosc-Marchenay N; Marit G; Hau F; Boiron JM; Reiffers J
Stem Cells; 1993 Jul; 11(4):326-35. PubMed ID: 8401256
[TBL] [Abstract][Full Text] [Related]
13. Autologous bone marrow transplantation in non-Hodgkin's lymphomas: prediction of mononuclear cell yield in bone marrow harvests.
Rinaldi C; Savignano C; Silvestri F; Geromin A; Cerno M; Fanin R; Biffoni F; Baccarani M
Haematologica; 1995; 80(5):443-7. PubMed ID: 8566888
[TBL] [Abstract][Full Text] [Related]
14. Long-term cultures to evaluate engraftment potential of CD34+ cells from peripheral blood after mobilization by chemotherapy with and without GM-CSF.
Benboubker L; Domenech J; Linassier C; Desbois I; Delain M; Lamagnere JP; Colombat P; Binet C
Exp Hematol; 1995 Dec; 23(14):1568-73. PubMed ID: 8542948
[TBL] [Abstract][Full Text] [Related]
15. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
16. Primitive hematopoietic progenitor cells are present in peripheral blood autografts.
Tong J; Gianni AM; Siena S; Srour EF; Bregni M; Hoffman R
Blood Cells; 1994; 20(2-3):351-62; discussion 362-3. PubMed ID: 7538339
[TBL] [Abstract][Full Text] [Related]
17. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H
Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
[TBL] [Abstract][Full Text] [Related]
18. In vitro busulfan sensitivity of granulocyte-macrophage and erythroid progenitor cells in patients with chronic myelogenous leukemia.
Kubota K; Preisler HD; Costanzo C; Miura Y
Cancer Res; 1983 Dec; 43(12 Pt 1):6090-3. PubMed ID: 6580066
[TBL] [Abstract][Full Text] [Related]
19. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
Hassan HT; Zeller W; Stockschläder M; Krüger W; Hoffknecht MM; Zander AR
Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
